Which clinical condition would warrant the administration of diphenhydramine?

A. Inflamed nasal cavity: Diphenhydramine is a first-generation antihistamine that blocks H1 receptors, reducing histamine-mediated inflammation in the nasal mucosa. It helps relieve symptoms such as nasal congestion, sneezing, and watery discharge associated with allergic rhinitis or other histamine-driven conditions. Its anticholinergic properties also contribute to decreased nasal secretions. B. Constricted bronchioles: Bronchoconstriction, as seen in asthma or severe allergic reactions, is primarily treated with bronchodilators like beta-agonists or epinephrine. Diphenhydramine does not effectively relieve airway constriction and is not the first-line therapy for bronchospasm. C. Cough and congestion: While diphenhydramine can have some mild sedative or antitussive effects, it does not thin mucus or act as an expectorant. Products such as guaifenesin or decongestants are more effective for loosening secretions and relieving cough with congestion. D. Pulmonary edema: Pulmonary edema involves fluid accumulation in the alveoli, typically from heart failure or acute injury. Management requires diuretics, oxygen therapy, and treatment of underlying causes. Diphenhydramine has no role in reducing alveolar fluid or improving gas exchange in this condition.